A side-by-side prospective study of intense pulsed light and Nd:YAG laser treatment for vascular lesions

Annals of Plastic Surgery

Volumn 56, Issue 2, 2006, Pages 164-170

  Fodor, Lucian ^a   Ramon, Ytzhack ^a   Fodor, Adriana ^a   Carmi, Nurit ^a   Peled, Isaac J ^a   Ullmann, Yehuda ^a,b  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b RAMBAM MEDICAL CENTER   (Israel)

Author keywords

IPL; Nd:YAG; Satisfaction level; Vascular lesions

Indexed keywords

ADULT; ANGIOMA; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HYPERPIGMENTATION; INTENSE PULSE LIGHT; MALE; NEODYMIUM LASER; PATIENT SATISFACTION; PHOTOTHERAPY; PRIORITY JOURNAL; TELANGIECTASIA; VASCULAR LESION; YAG LASER;

ADULT; FEMALE; HEMANGIOMA; HUMANS; HYPERPIGMENTATION; LASER THERAPY, LOW-LEVEL; MALE; MIDDLE AGED; PATIENT SATISFACTION; PHOTOTHERAPY; SKIN DISEASES, VASCULAR; TELANGIECTASIS; VARICOSE VEINS;

EID: 33645067379     PISSN: 01487043     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.sap.0000196579.14954.d6     Document Type: Article

References (30)

1. Engel A, Johnson ML, Hayes SG. Health effects of sunlight exposure in the United States: results from the first National Health and Nutrition Examination Survey 1971-1974. Arch Dermatol. 1998;124:72-79.
2. Bernstein EF. Clinical characteristics of 500 consecutive patients presenting for laser removal of lower extremity spider veins. Dermatol Surg. 2001;27:31-33.
3. Weiss RA, Weiss MA. Resolution of pain associated with varicose and telangiectatic leg veins after compression sclerotherapy. J Dermatol Surg Oncol. 1990;16:333-336.
4. Gupta G, Bilsland D. A prospective study of the impact of laser treatment on vascular lesions. Br J Dermatol. 2000;143:356-359.
5. Green D. Sclerotherapy for the permanent eradication of varicose veins: theoretical and practical considerations. J Am Acad Derm. 1998;22:323-330.
6. Bernstein EF, Kornbluth S, Brown DB, et al. Treatment of spider veins using a 10 millisecond pulse-duration frequency-doubled neodymium YAG laser. Dermatol Surg. 1999;25:316-320.
7. Dover JS, Sadick NS, Goldman MP. The role of lasers and light sources in the treatment of leg veins. Dermatol Surg. 1999;25:328-336.
8. Goldman MP, Bennett RG. Treatment of telangiectasia: a review. J Am Acad Derm. 1987;17:167-182.
9. Goldman MP, Eckhouse S. Photothermal sclerosis of leg veins. Dermatol Surg. 1996;22:323-330.
10. Mordon S, Bristot D, Founder N. Using a "nonuniform pulse sequence" can improve selective coagulation with a Nd: YAG laser (1.06 microm) thanks to Met-hemoglobin absorption: a clinical study on blue leg veins. Lasers Surg Med. 2003;32:160-170.
11. Dierickx CC, Casparian JM, Venugopalan V, et al. Thermal relaxation of port-wine stain vessels probed in vivo: the need for 1-10 millisecond laser pulse treatment. J Invest Dermat. 1995;105:709-714.
12. Sadick NS. Long-term results with multiple synchronized-pulse 1064 nm Nd:YAG laser for the treatment of leg venulectasias and reticular veins. Dermatol Surg. 2001;27:365-369.
13. Adrian RM. Treatment of leg telangiectasias using a long-pulse frequency-doubled neodymium:YAG laser at 532 nm. Dermatol Surg. 1998;24:19-23.
14. Bernstein EF, Lee J, Lowery J, et al. Treatment of spider veins with the 595 nm pulsed-dye laser. J Am Acad Derm. 1998;39:746-750.
15. Schroeter CA, Wilder D, Reinke T, et al. Clinical significance of an intense pulsed light source on leg telangiectasias of up to 1 mm in diameter. Eur J Dermatol. 1997;7:38-42.
16. Weiss RA, Weiss MA. Early clinical results with a multiple synchronized pulse 1064 nm laser for leg telangiectasias and reticular veins. Dermatol Surg. 1999;25:399-402.
17. Schroeter CA, Neumann HAM. An intense light source: the photoderm vs. flash lamp or a new treatment possibility of vascular skin lesions. Dermatol Surg. 1998;24:743-748.
18. Gambichler T, Avermaete A, Wilmert M, et al. Generalized essential telangiectasia successfully treated with high-energy, long-pulse, frequency-doubled Nd:YAG laser. Dermatol Surg. 2001;27:355-357.
19. Rogachefsky A, Silapunt S, Golberg DJ. Nd:YAG laser (1064) irradiation for lower extremity telangiectases and small reticular veins: efficacy as measured by vessel color and size. Dermatol Surg. 2002;28:220-223.
20. Sadick NS. A dual wavelength approach for laser/intense pulsed light source treatment of lower extremity veins. J Am Acad Derm. 2002;46:66-72.
21. Major A, Brazzini B, Campolmi P, et al. Nd:YAG 1064 nm laser in the treatment of facial and leg telangiectasias. J Eur Acad Derm Vener. 2001;15:559-565.
22. Hercogova J, Brazzini B, Hautmann G, et al. Laser treatment of cutaneous vascular lesions: face and leg telangiectases. J Eur Acad Derm Vener. 2002;16:12-18.
23. Omura NE, Dover JS, Arndt KA, et al. Treatment of reticular leg veins with a 1064 nm long-pulsed Nd:YAG laser. J Am Acad Derm. 2003;48:76-81.
24. Coles MC, Werner RS, Zelickson BD. Comparative pilot study evaluating the treatment of leg veins with a long pulse Nd:YAG laser and sclerotherapy. Lasers Surg Med. 2002;30:154-159.
25. Massey RA, Katz BE. Successful treatment of spider leg veins with a high-energy, long-pulse, frequency-doubled neodymium:YAG laser (HELP-G). Dermatol Surg. 1999;25:677-680.
26. Goldberg DJ, Meine JG. A comparison of four frequency-doubled Nd:YAG (532) laser systems for treatment of facial telangiectases. Dermatol Surg. 1999;25:463-467.
27. Eremia S, Li Do CY. Treatment of face veins with cryogen spray variable pulse width 1064 nm Nd:YAG laser: a prospective study of 17 patients. Dermatol Surg. 2002;28:244-247.
28. Eremia S, Li Do C, Umar SH. A side-by-side comparative study of 1064 nm Nd: YAG, 810 nm diode and 755 nm alexandrite lasers for treatment of 0.3-3 mm leg veins. Dermatol Surg. 2002;28:224-230.
29. Lupton JR, Alster T, Romero P. Clinical comparison of sclerotherapy versus long-pulsed Nd:YAG laser treatment for lower extremity telangiectases. Dermatol Surg. 2002;28:694-697.
30. Trelles MA, Allones I, Martin-Vasquez MJ, et al. Long pulse Nd:YAG laser for treatment of leg veins in 40 patients with assessment at 6 and 12 months. Lasers Surg Med. 2004;35:68-76.